North America Patient Warming Systems Market Report Scope & Overview:

The North America Patient Warming Systems Market was valued at USD 0.83 Billion in 2025 and is expected to reach USD 1.58 Billion by 2035, growing at a CAGR of 6.61% from 2026-2035.

The North America Patient Warming Systems Market is expanding as hospitals and ambulatory surgical centers scale up perioperative temperature-management protocols to reduce surgical site infections and post-anesthesia complications. Growing surgical volumes, an aging population with higher comorbidity burdens, and expanding neonatal intensive care capacity are each widening demand for forced-air, conductive, and fluid-warming devices. Manufacturers are investing in single-use and disposable warming blankets to meet infection-control guidelines, while hospital systems increasingly bundle normothermia management into standardized perioperative care pathways. Growing outpatient surgical volume at ambulatory surgical centers is extending demand for compact warming systems beyond traditional hospital operating rooms across the region.

⮞The Centers for Disease Control and Prevention’s perioperative normothermia guidelines continue to anchor U.S. hospital purchasing of active warming systems in 2025. North America held approximately 38.76% share of the global Patient Warming Systems Market in 2025, while Asia Pacific is forecast to post the fastest regional CAGR of 8.35% from 2026-2035.

North America Patient Warming Systems Market Trends:

• Expanding ambulatory surgical center capacity is widening demand for compact, single-use warming systems beyond hospital operating rooms.

• Growing adoption of fluid and blood warming devices is supporting trauma and emergency-care normothermia protocols.

• Rising neonatal intensive care admissions are increasing demand for radiant and conductive warming devices.

• Hospital infection-control guidelines are accelerating the shift toward disposable, single-patient-use warming blankets.

• Growing distribution partnerships are expanding hospital rental access to advanced fluid-warming equipment nationwide.

U.S. Patient Warming Systems Market Outlook:

The U.S. Patient Warming Systems Market was valued at USD 0.70 Billion in 2025 and is expected to reach USD 1.26 Billion by 2035, growing at a CAGR of 6.13% from 2026-2035.

The U.S. Patient Warming Systems Market is advancing as hospitals standardize perioperative normothermia protocols across surgical and emergency departments nationwide. Growing surgical case volumes, rising adoption of enhanced-recovery-after-surgery pathways, and expanding ambulatory surgical center capacity are each widening the addressable patient base for both capital equipment and disposable warming products. Solventum, Stryker, and Medtronic continue to expand distribution and rental partnerships with hospital systems, while newer entrants are advancing fluid and blood warming platforms for trauma and emergency-care settings. Growing neonatal intensive care admissions are further reinforcing demand for radiant warmer capacity across pediatric and maternity hospital departments nationwide.

⮞Solventum completed its separation from 3M in April 2024 and now operates the Bair Hugger patient warming product line as an independent NYSE-listed company serving U.S. hospital systems.

By Product Type, Forced Air Warming Systems Dominate the North America Patient Warming Systems Market, Fluid & Blood Warming Systems Grow Fastest

Forced air warming systems retained the largest product share across North America in 2025, supported by their established efficacy record in maintaining intraoperative normothermia and broad hospital purchasing familiarity built over several procurement cycles. Solventum’s Bair Hugger platform and Stryker’s warming portfolio continue to anchor hospital capital equipment budgets, reinforcing this lead even as newer fluid-warming and conductive technologies expand their own clinical evidence base and marketing reach across surgical and emergency-care departments nationwide. This dynamic is expected to persist through the remainder of the 2026-2035 forecast window as manufacturers and hospital purchasers continue adjusting procurement to shifting demand.

Fluid & blood warming systems are forecast to grow fastest through 2035 as trauma centers and emergency departments expand rapid-infusion warming capacity for hemorrhage and transfusion protocols. QinFlow’s Warrior AC Station launch and Belmont Medical Technologies’ Premier Inc. national agreement are reinforcing this category’s momentum, converting growing trauma-care demand into capital equipment purchases faster than any other product category across the region. Continued investment in local commercial infrastructure and distribution is expected to reinforce this pattern through 2035 as hospital procurement cycles evolve across the market. This is expected to continue through 2035.

By Application, Intraoperative Care Dominates the North America Patient Warming Systems Market, Neonatal Care Grows Fastest

Intraoperative care applications remain the largest contributor given the established link between perioperative hypothermia and surgical site infection risk, which has anchored active warming protocols as a standard-of-care practice across hospital operating rooms. Physician familiarity with forced-air and conductive warming during surgery, combined with long-standing hospital procurement cycles for operating room equipment, continues to concentrate volumes in this application across the region’s largest hospital systems and ambulatory surgical centers. Growing hospital familiarity with this technology and expanding clinical guideline support are expected to sustain this trajectory through the remainder of the forecast period.

Neonatal care is set to post the fastest growth as expanding neonatal intensive care unit capacity and rising preterm birth rates increase demand for radiant warmers and conductive warming mattresses. Growing hospital investment in dedicated neonatal and maternity department infrastructure, combined with expanding clinical guidelines on newborn thermoregulation, is accelerating conversion of latent demand into equipment purchases across both the United States and Canada. Rising procurement activity and continued manufacturer investment are expected to reinforce this trend across the market through 2035. This trend is expected to strengthen further.

By Technology, Convective Dominates the North America Patient Warming Systems Market, Conductive Grows Fastest

Convective warming technology continues to dominate given its established efficacy record and the long clinical history behind forced-air systems used across most North American operating rooms. Established manufacturing scale, broad hospital purchasing familiarity, and years of clinical evidence supporting convective normothermia maintenance further reinforce this technology’s lead, even as conductive alternatives gain clinical attention from hospital systems seeking lower-noise, lower-airflow-disruption alternatives for sterile operating environments. This dynamic is expected to persist through the remainder of the 2026-2035 forecast window as manufacturers and hospital purchasers continue adjusting procurement to shifting demand.

Conductive warming technology is growing fastest as hospitals increasingly adopt resistive polymer and underbody warming mattresses that avoid forced-air circulation in sterile fields. Growing clinical evidence supporting conductive warming’s infection-control advantages, combined with expanding adoption in orthopedic and cardiac surgical suites, is accelerating this technology’s growth faster than any other category across both the United States and Canada through the forecast period. Continued investment in local commercial infrastructure and distribution is expected to reinforce this pattern through 2035 as hospital procurement cycles evolve across the market. This pattern is likely to persist across the forecast period.

By End User, Hospitals Dominate the North America Patient Warming Systems Market, Ambulatory Surgical Centers Grow Fastest

Hospitals remain the primary end user given their dense surgical volume, established capital equipment budgets, and comprehensive perioperative care protocols spanning preoperative, intraoperative, and postoperative warming needs. Long-standing group purchasing organization contracts, broad departmental coverage across surgery, emergency, and neonatal units, and continued infection-control compliance requirements keep hospitals the central purchaser of both capital warming equipment and disposable consumables across the region. Growing hospital familiarity with this technology and expanding clinical guideline support are expected to sustain this trajectory through the remainder of the forecast period. This is expected to support continued category growth.

Ambulatory surgical centers are growing fastest as outpatient surgical volume continues to shift away from traditional hospital settings toward lower-cost, higher-throughput surgical facilities. Expanding same-day surgery volume and growing adoption of compact, cost-effective warming systems designed for smaller operating suites are reinforcing this channel’s rapid growth across both the United States and Canada through the forecast period. Rising procurement activity and continued manufacturer investment are expected to reinforce this trend across the market through 2035. This is expected to continue through 2035. This trajectory is expected to continue reshaping procurement patterns through the remainder of the decade.

Regional Analysis:

U.S. Patient Warming Systems Market Insights

The U.S. dominated the North America Patient Warming Systems Market with the highest revenue share of about 83.67% in 2025, supported by the largest base of hospital surgical volume in the region, dense ambulatory surgical center infrastructure, and the concentration of leading manufacturer headquarters and distribution networks within the country. The presence of major hospital systems, established group purchasing organizations, and continuous product innovation from Solventum and Stryker keep the United States the primary revenue engine for the regional market across nearly every product and application category. This talent and infrastructure density continues to widen the gap between the U.S. and every other North America market.

Growing ambulatory surgical center capacity, expanding neonatal intensive care investment, and rising adoption of disposable single-patient-use warming products across major U.S. metropolitan hospital networks continue to reinforce U.S. dominance within North America. Ongoing distribution partnership expansion between device manufacturers and hospital rental companies is further widening access to advanced fluid and blood warming equipment, allowing deferred capital equipment demand to convert into sustained purchasing growth through 2035. This dynamic is expected to persist through the remainder of the 2026-2035 forecast window as manufacturers and hospital purchasers continue adjusting procurement to shifting demand.

Canada Patient Warming Systems Market Insights

The Canada segment is expected to grow at the fastest CAGR of about 9.20% from 2026–2035, facilitated by expanding provincial hospital capital equipment budgets and growing adoption of perioperative normothermia protocols across major Canadian hospital networks. Rising surgical volumes, increasing neonatal intensive care investment, and growing physician familiarity with fluid and blood warming equipment are accelerating patient warming systems adoption across Canadian provinces, narrowing the per-capita treatment gap with the United States over the forecast period. Continued investment in local commercial infrastructure and distribution is expected to reinforce this pattern through 2035 as hospital procurement cycles evolve across the market.

Moreover, continued investment by Solventum and Stryker in Canadian distribution infrastructure, combined with growing provincial health authority focus on surgical site infection prevention, is supporting faster hospital procurement cycles for both capital and disposable warming products. Expanding ambulatory surgical center capacity across Ontario, Quebec, and British Columbia is expected to further reinforce Canada’s above-regional growth rate through 2035. Growing hospital familiarity with this technology and expanding clinical guideline support are expected to sustain this trajectory through the remainder of the forecast period. This trend is expected to strengthen further.

Market Dynamics:

Growth Drivers: Rising surgical volumes and growing emphasis on perioperative normothermia are increasing demand for patient warming systems.

The North American surgical cases are going up with the growing elderly population due to the increase in orthopedic, heart and cancer surgery cases. In order to reduce infection at the surgery point and shivering during recovery after anesthesia, the hospitals in North America have standardized warming devices. There is strong evidence that by keeping body temperatures normal during the surgery process, shorter hospital stay and less complications occur. This has made it easier for the doctors and hospital executives to require the use of warming devices in the surgical departments. The expansion of ambulatory surgical centers and NICU admissions also makes the market larger.

Restraints: High capital equipment costs and budget constraints at smaller healthcare facilities continue to limit broader adoption.

The initial cost of installation remains an issue among smaller hospitals, rural healthcare centers, and independent ASCs that have small budgets due to low capital. In spite of favorable pricing among large hospital systems with the use of contracts in Group Purchasing Organization (GPO), other organizations have to enter into equipment rental agreements. As such, instead of paying only once as in capital expenses, the facility faces ongoing operational expenses. Other costs associated with disposables such as warming blankets will keep building up especially among the high surgery volume departments. This problem is solved through delaying replacement of the equipment after it expires from the manufacturer.

Opportunities: Expansion of fluid and blood warming technology into trauma and emergency-care settings creates new growth avenues.

Rapid-infusion fluid and blood warming platforms designed for trauma and emergency-department hemorrhage protocols are opening new purchasing pathways well beyond traditional operating room equipment. Growing clinical guidelines around massive transfusion protocols and prehospital trauma care are expanding the addressable market for portable and rapid-deployment warming devices. Continued distribution partnership expansion between manufacturers and hospital rental companies is also expected to widen access to advanced warming technology across smaller facilities that previously could not justify the capital investment. This dynamic is expected to persist through the remainder of the 2026-2035 forecast window as manufacturers and hospital purchasers continue adjusting procurement to shifting demand.

North America Patient Warming Systems Market Key Players are:

• Solventum Corporation

• Stryker Corporation

• Medtronic plc

• Gentherm Incorporated

• Belmont Medical Technologies

• ICU Medical, Inc.

• Becton, Dickinson and Company

• ZOLL Medical Corporation

• Avanos Medical, Inc.

• Encompass Group, LLC

• Cardinal Health, Inc.

• GE HealthCare Technologies Inc.

• Inspiration Healthcare Group plc

• Quality In Flow Ltd.

• Geratherm Medical AG

• The 37Company

• VitaHEAT Medical

• Barkey GmbH & Co. KG

• Inditherm plc

• Drägerwerk AG & Co. KGaA

North America Patient Warming Systems Market Report Scope: